PTC Therapeutics, Inc. (PTCT) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Ptc Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:02.355 Ladies and gentlemen, thank you for standing by. 00:00:02.355 -- 00:00:08.105 Welcome to PTC Therapeutics' first quarter 2026 earnings conference call. 00:00:08.105 -- 00:00:12.212 All participants on a listen-only mode. After the speaker's presentation, there will 00:00:12.212 -- 00:00:17.040 be a Q&A session. Today's conference is being recorded. 00:00:17.040 -- 00:00:21.648 I would now like to send the call over to Ellen Cavallari, Head of Investillations. 00:00:21.648 -- 00:00:24.069 Please go ahead. 00:00:26.660 -- 00:00:31.265 Good afternoon, and thank you for joining us to discuss PTC Therapeutics' first quarter 00:00:31.265 -- 00:00:35.009 2026 corporate update and financial results. 00:00:35.009 -- 00:00:37.651 I'm joined today by our Chief Executive Officer, Dr. 00:00:37.651 -- 00:00:42.356 Matthew Klein, our Chief Business Officer, Eric Powles, and our Chief Financial Officer, 00:00:42.356 -- 00:00:47.081 Pierre Gravier. Today's call will include forward-looking statements based on our current 00:00:47.081 -- 00:00:51.726 expectations. These statements are subject to certain risks and uncertainties, and actual 00:00:51.726 -- 00:00:56.320 results may differ materially. Please review the slide posted on our investor relations 00:00:56.320 -- 00:01:00.686 website in conjunction with the call, which contains information about our forward-looking 00:01:00.686 -- 00:01:05.713 statements and our most recent quarterly report on Form 10-Q and annual report on 00:01:05.713 -- 00:01:10.940 Form 10-K filed with the SEC, as well as our other SEC filings 00:01:10.940 -- 00:01:15.165 for a detailed description of applicable risks and uncertainties that could cause our 00:01:15.165 -- 00:01:19.951 actual performance and results to diff...